Honor Healthcare Limited 12525512 false 2024-10-01 2025-03-31 2025-03-31 The principal activity of the company is is that of retail pharmacy. Digita Accounts Production Advanced 6.30.9574.0 true true 12525512 2024-10-01 2025-03-31 12525512 2025-03-31 12525512 core:AcceleratedTaxDepreciationDeferredTax 2025-03-31 12525512 core:CurrentFinancialInstruments 2025-03-31 12525512 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 12525512 core:Non-currentFinancialInstruments 2025-03-31 12525512 core:Non-currentFinancialInstruments core:AfterOneYear 2025-03-31 12525512 core:Goodwill 2025-03-31 12525512 core:FurnitureFittingsToolsEquipment 2025-03-31 12525512 core:MotorVehicles 2025-03-31 12525512 core:OtherPropertyPlantEquipment 2025-03-31 12525512 core:OtherProvisionsContingentLiabilities 2025-03-31 12525512 bus:SmallEntities 2024-10-01 2025-03-31 12525512 bus:AuditExemptWithAccountantsReport 2024-10-01 2025-03-31 12525512 bus:FilletedAccounts 2024-10-01 2025-03-31 12525512 bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-03-31 12525512 bus:RegisteredOffice 2024-10-01 2025-03-31 12525512 bus:Director1 2024-10-01 2025-03-31 12525512 bus:Director3 2024-10-01 2025-03-31 12525512 bus:Director4 2024-10-01 2025-03-31 12525512 bus:Director5 2024-10-01 2025-03-31 12525512 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-03-31 12525512 bus:Agent1 2024-10-01 2025-03-31 12525512 core:Goodwill 2024-10-01 2025-03-31 12525512 core:FurnitureFittingsToolsEquipment 2024-10-01 2025-03-31 12525512 core:MotorVehicles 2024-10-01 2025-03-31 12525512 core:OfficeEquipment 2024-10-01 2025-03-31 12525512 core:OtherPropertyPlantEquipment 2024-10-01 2025-03-31 12525512 core:OtherProvisionsContingentLiabilities 2024-10-01 2025-03-31 12525512 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2024-10-01 2025-03-31 12525512 core:OtherRelatedParties 2024-10-01 2025-03-31 12525512 core:OtherRelatedPartyRelationshipType1ComponentTotalRelatedParties 2024-10-01 2025-03-31 12525512 core:OtherRelatedPartyRelationshipType2ComponentTotalRelatedParties 2024-10-01 2025-03-31 12525512 core:ParentEntities 2024-10-01 2025-03-31 12525512 countries:EnglandWales 2024-10-01 2025-03-31 12525512 2024-09-30 12525512 core:Goodwill 2024-09-30 12525512 core:FurnitureFittingsToolsEquipment 2024-09-30 12525512 core:MotorVehicles 2024-09-30 12525512 core:OtherPropertyPlantEquipment 2024-09-30 12525512 2023-04-01 2024-09-30 12525512 2024-09-30 12525512 core:AcceleratedTaxDepreciationDeferredTax 2024-09-30 12525512 core:CurrentFinancialInstruments 2024-09-30 12525512 core:CurrentFinancialInstruments core:WithinOneYear 2024-09-30 12525512 core:Non-currentFinancialInstruments 2024-09-30 12525512 core:Non-currentFinancialInstruments core:AfterOneYear 2024-09-30 12525512 core:Goodwill 2024-09-30 12525512 core:FurnitureFittingsToolsEquipment 2024-09-30 12525512 core:MotorVehicles 2024-09-30 12525512 core:OtherPropertyPlantEquipment 2024-09-30 iso4217:GBP xbrli:pure

Registration number: 12525512

Prepared for the registrar

Honor Healthcare Limited

Annual Report and Unaudited Financial Statements

for the Period from 1 October 2024 to 31 March 2025

 

Honor Healthcare Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 10

 

Honor Healthcare Limited

Company Information

Directors

T J Masamha

M Talib

A Talib

C Mlia

Registered office

77 Westbourne Avenue
Hull
HU5 3HW

Accountants

Hazlewoods LLP Windsor House
Bayshill Rd
Cheltenham
GL50 3AT

 

Honor Healthcare Limited

(Registration number: 12525512)
Balance Sheet as at 31 March 2025

Note

31 March
2025
£

30 September
2024
£

Fixed assets

 

Intangible assets

4

1,030,598

1,063,489

Tangible assets

5

120,252

130,937

 

1,150,850

1,194,426

Current assets

 

Stocks

74,732

49,368

Debtors

6

190,451

173,796

Cash at bank and in hand

 

7,167

43,964

 

272,350

267,128

Creditors: Amounts falling due within one year

7

(1,345,841)

(531,512)

Net current liabilities

 

(1,073,491)

(264,384)

Total assets less current liabilities

 

77,359

930,042

Creditors: Amounts falling due after more than one year

7

-

(864,254)

Provisions

8

(22,573)

-

Deferred tax liabilities

10

(29,098)

(31,748)

Provisions for liabilities

(51,671)

(31,748)

Net assets

 

25,688

34,040

Capital and reserves

 

Called up share capital

1,000

1,000

Retained earnings

24,688

33,040

Shareholders' funds

 

25,688

34,040

For the financial period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 15 December 2025 and signed on its behalf by:
 


T J Masamha
Director

 

Honor Healthcare Limited

Notes to the Unaudited Financial Statements for the Period from 1 October 2024 to 31 March 2025

 

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
77 Westbourne Avenue
Hull
HU5 3HW
United Kingdom

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Going concern

After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
 

Judgements

No significant judgements have been made by management in preparing these financial statements.

Key sources of estimation uncertainty

No key sources of estimation uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts and after eliminating sales within the company.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

 

Honor Healthcare Limited

Notes to the Unaudited Financial Statements for the Period from 1 October 2024 to 31 March 2025

Tax

The tax expense for the period comprises and deferred tax. Tax is recognised in the profit and loss account, except that a charge attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred income tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office equipment

25% reducing balance basis

Fixtures & fittings

10% reducing balance basis

Motor Vehicles

25% reducing balance basis

Goodwill

Goodwill is amortised over its useful life, estimated by the directors to be 20 years.

Intangible assets

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date.

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.

Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

Honor Healthcare Limited

Notes to the Unaudited Financial Statements for the Period from 1 October 2024 to 31 March 2025

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. All trade debtors are repayable within one year and hence are included at the undiscounted cost of cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the debtors.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Provisions

Provisions are recognised when the company has an obligation at the reporting date as a result of a past event, it is probable that the company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

 

Honor Healthcare Limited

Notes to the Unaudited Financial Statements for the Period from 1 October 2024 to 31 March 2025

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.


Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.


Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

 

3

Staff numbers

The average number of persons employed by the company (including directors) during the period, was as follows:

 

Honor Healthcare Limited

Notes to the Unaudited Financial Statements for the Period from 1 October 2024 to 31 March 2025

 

4

Intangible assets

Goodwill
 £

Total
£

Cost

At 1 October 2024

1,315,656

1,315,656

At 31 March 2025

1,315,656

1,315,656

Amortisation

At 1 October 2024

252,167

252,167

Amortisation charge

32,891

32,891

At 31 March 2025

285,058

285,058

Carrying amount

At 31 March 2025

1,030,598

1,030,598

At 30 September 2024

1,063,489

1,063,489

 

5

Tangible assets

Leasehold property improvements
£

Furniture, fittings and equipment
 £

Motor vehicles
 £

Total
£

Cost

At 1 October 2024

73,937

174,804

3,500

252,241

At 31 March 2025

73,937

174,804

3,500

252,241

Depreciation

At 1 October 2024

13,021

105,842

2,441

121,304

Charge for the period

2,031

8,522

132

10,685

At 31 March 2025

15,052

114,364

2,573

131,989

Carrying amount

At 31 March 2025

58,885

60,440

927

120,252

At 30 September 2024

60,916

68,962

1,059

130,937

 

Honor Healthcare Limited

Notes to the Unaudited Financial Statements for the Period from 1 October 2024 to 31 March 2025

 

6

Debtors

31 March 2025
£

30 September 2024
£

Trade debtors

161,827

162,360

Prepayments

7,778

11,436

Other debtors

20,846

-

190,451

173,796

 

7

Creditors

Note

31 March
2025
£

30 September 2024
£

Due within one year

 

Loans and borrowings

9

-

48,000

Trade creditors

 

180,659

122,922

Amounts due to related parties

11

1,132,314

306,122

Taxation and social security

 

16,470

49,588

Accruals and deferred income

 

15,675

4,250

Other creditors

 

723

630

 

1,345,841

531,512

Note

31 March
2025
£

30 September 2024
£

Due after one year

 

Loans and borrowings

9

-

864,254

 

8

Provisions

NHS reimbursement
£

Total
£

Additional provisions

22,573

22,573

At 31 March 2025

22,573

22,573

The NHS reimbursement provision is to cover clawback of potential over-reimbursement received in the current financial year, which will be clawed back over the next 12 months.

 

Honor Healthcare Limited

Notes to the Unaudited Financial Statements for the Period from 1 October 2024 to 31 March 2025

 

9

Loans and borrowings

Current loans and borrowings

31 March
2025
£

30 September
2024
£

Bank borrowings

-

48,000

Non-current loans and borrowings

31 March
2025
£

30 September
2024
£

Bank borrowings

-

864,254

The bank loans are secured against the assets of the company.

 

10

Deferred tax

Deferred tax assets and liabilities

31 March 2025

Liability
£

Difference between accumulated depreciation and amortisation and capital allowances

29,098

29,098

30 September 2024

Liability
£

Difference between accumulated depreciation and amortisation and capital allowances

31,748

31,748

 

Honor Healthcare Limited

Notes to the Unaudited Financial Statements for the Period from 1 October 2024 to 31 March 2025

 

11

Related party transactions

Summary of transactions with key management

Key management personnel are considered to be the directors of the company.

As at the year end, the company owed the directors £nil (2024 - £301,122). There were no fixed repayment terms and no interest is charged.

 

Summary of transactions with other related parties

Summary of transactions with parent

Chaltamo Clover Ltd At the balance sheet date the company owed Chaltamo Clover Ltd £1,147,814 (2024 - £nil). There are no fixed repayment terms and no interest is charged.

Summary of transactions with other related parties

Tavita Ltd (T J Masamha is also a director of Tavita Limited)
At the balance sheet date the company owed Tavita Limited £nil (2024 - £5,000). There are no fixed repayment terms and no interest is charged.

Whistlers (Newark) Ltd (Common directors/shareholders)
At the balance sheet date the company owed Whistlers (Newark) Ltd £5,000 (2024 - £nil). There are no fixed repayment terms and no interest is charged.

D.L. Ogle Limited
(Common directors/shareholders)
At the balance sheet date the company was owed £20,500 (2024 - £nil) by D. L. Ogle Limited. There are no fixed repayment terms and no interest is charged